Centers | ||
Therapeutic Accelerator Program (TAP) | Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | Presude Life Sciences |
Test |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
Presude Lifesciences is an integrated drug discovery and development services organization led by biopharma professionals with global experience. Read morePresude is a research driven company with expertise in medicinal chemistry, custom synthesis and... |
Partnerships |
Events |
Jobs |
SDDCThe DDU is now leading the SDDC. The Structure-guided Drug Discovery Coalition (SDDC) is an international research coalition led by the Structural Genomics Consortium, based at McGill University, Canada. The mission of the SDDC is to contribute to... View all CWHM/OWH Childhood DiarrheaCWHM signed a joint research agreement in 2010 with the Institute for One World Health to discover and develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children under age 5. Under the agreement, CWHM... View all Vanderbilt Enters Into Collaboration With BMS to Develop Drugs to treat Parkinsons DiseaseVanderbilt Center for Neuroscience Drug Discovery (VCNDD) and Bristol-Myers Squibb Company have entered into a broad collaboration agreement to co-develop new drugs to treat Parkinsons Disease. Under the collaboration agreement VCNDD will identify... View all |
No EVENTS for listing |
No Job Posts |


